We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug Discovery

News   May 21, 2018 | Original story from PhoreMost

 
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug Discovery

Dr Chris Torrance, CEO at PhoreMost Ltd.

 
 
 

RELATED ARTICLES

Poo Transplant Shows Promise in Prelim Study for Ulcerative Colitis

News

Anaerobically prepared fecal microbiota transplantation improved remission rates in people with moderately active ulcerative colitis at 8 weeks. Further research is needed to assess longer-term efficacy and safety.

READ MORE

Gene Promotes Resistance to Prostate Cancer Treatments

News

Researchers have discovered how a gene involved in regulating hormone receptors may contribute to drug resistance in some prostate cancer patients.

READ MORE

Concern Over Fake ISO 9001 Accreditation of Chinese Companies

News

A study concludes that fake ISO 9001 quality certificates are very widespread across Chinese companies and that the certification processes of the auditing companies lack credibility.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE